(Q33896160)

29 July 2017

1 reference

title

Antiretroviral therapy: state of the HAART. (English)

1 reference

29 July 2017

main subject

anti-retroviral agent

0 references

author name string

Vella S

series ordinal

1

1 reference

29 July 2017

Palmisano L

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

45

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-7

1 reference

Restoration of the immune system with anti-retroviral therapy

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Induction/maintenance treatment regimens for HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Antiretroviral treatment in 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

HIV treatment failure: testing for HIV resistance in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900068-6

7 January 2021

10.1016/S0166-3542(99)00068-6

Identifiers

DOI

1 reference

29 July 2017

1 reference